| Breakdown | TTM | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 | Feb 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 4.78B | 4.76B | 4.72B | 4.01B | 3.62B | 2.55B |
| Gross Profit | 520.74M | 532.93M | 516.08M | 448.41M | 435.42M | 301.02M |
| EBITDA | 88.92M | 89.80M | 93.57M | 75.22M | 93.42M | 44.88M |
| Net Income | 16.42M | 18.10M | 25.71M | 25.53M | 60.00M | 16.32M |
Balance Sheet | ||||||
| Total Assets | 1.54B | 1.58B | 1.48B | 1.38B | 1.06B | 1.16B |
| Cash, Cash Equivalents and Short-Term Investments | 58.50M | 72.65M | 70.60M | 78.98M | 83.79M | 67.83M |
| Total Debt | 240.71M | 233.22M | 207.50M | 237.80M | 156.46M | 163.46M |
| Total Liabilities | 1.18B | 1.22B | 1.13B | 1.04B | 725.51M | 885.23M |
| Stockholders Equity | 363.97M | 357.55M | 353.37M | 341.38M | 331.88M | 275.94M |
Cash Flow | ||||||
| Free Cash Flow | 56.55M | 39.80M | 57.02M | 59.39M | 52.39M | 60.10M |
| Operating Cash Flow | 82.29M | 66.64M | 83.97M | 80.83M | 69.00M | 74.92M |
| Investing Cash Flow | -28.14M | -32.37M | -29.11M | -143.33M | -24.52M | -33.64M |
| Financing Cash Flow | -34.30M | -32.22M | -63.23M | 57.69M | -28.52M | -14.29M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | £178.62M | 3.31 | 4.55% | 3.22% | -0.17% | -10.96% | |
70 Outperform | £2.77B | 10.60 | 23.83% | 3.44% | -15.99% | 69.97% | |
67 Neutral | £286.73M | 5.52 | -6.79% | 6.30% | 3.31% | -340.97% | |
62 Neutral | £17.30M | 4.36 | 30.82% | ― | -18.51% | -13.40% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
55 Neutral | £103.14M | 12.59 | 16.70% | 1.48% | 20.64% | ― | |
49 Neutral | £10.91M | -4.86 | -2.26% | 2.41% | 2.30% | 37.27% |